
UroGen Pharma Hits New 52-Week High of $23.89, Up 81.99%
2025-11-10 17:18:27UroGen Pharma achieved a new 52-week high of USD 23.89 on November 7, 2025, marking an 81.99% increase over the past year. With a market capitalization of USD 991 million, the company has a notable return on equity of 165.96%, despite being currently loss-making.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






